Targeting E2F1-downstream pathways in invasive bladder cancer for therapeutic intervention by combining CRISPR/Cas9-mediated genome editing and adenoviral vectors. - Institute for Experimental Gentherapy and Cancer Research

Jansen BA, Solanki M, Spitschak A, Rieger C, Erbersdobler A, Taher L, Heckl D, Herchenröder O, Füssel S, Pützer BM.

Targeting E2F1-downstream pathways in invasive bladder cancer for therapeutic intervention by combining CRISPR/Cas9-mediated genome editing and adenoviral vectors.

Human Gene Therapy 2017; 28(12):A24-A24. Meeting Abstract: P026.

2017

Endotheliale ICAM-Expression in Abhängigkeit der plazentaren Progranulinsynthese.

Parakrine Effekte der trophoblastären Progranulinexpression auf humane umbilikale Endohelzellen in-vitro.

Contact

Office

Institute for Experimental Gene Therapy and Cancer Research

Office

Links

News